Skin accumulation of advanced glycation endproducts is increased in AAA patients

Size: px
Start display at page:

Download "Skin accumulation of advanced glycation endproducts is increased in AAA patients"

Transcription

1 Skin accumulation of advanced glycation endproducts is increased in AAA patients Clark Zeebregts Professor of Vascular Surgery University Medical Center Groningen Department of Surgery Division of Vascular Surgery Groningen, The Netherlands Munich, Germany December 8, 2017

2 Disclosure Consultant for Vascutek Received research grants from W.L. Gore & Associates, LeMaitre Vascular, Atrium Maquet Getinge Group, and Cook Medical

3 Advanced glycation end products (AGEs) Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006; 114:

4 AGE Reader Courtesy by DiagnOptics, Groningen, The Netherlands.

5 AGEs and skin autofluorescence Formation and accumulation of AGEs in long-lived tissues occurs physiologically with ageing. Formation is enhanced in conditions associated with hyperglycemia or oxidative stress, such as DM, autoimmune disease, renal insufficiency and atherosclerosis. SAF is increased in patients with these conditions compared to controls. Increased SAF is associated with major adverse cardiovascular events in patients with DM, myocardial infarction and peripheral artery disease (PAD).

6 AGEs and AAA PAD and AAA disease share several risk factors and are frequently found in the same patient. Inflammation is an important pathway of AAA formation, mediating elastin and collagen degradation by proteases derived from inflammatory cells. Hypothesis: skin autofluorescence (SAF), as a measure of skin AGEs, is increased in patients with an AAA.

7 Aims of study To compare SAF levels in AAA patients and controls. To investigate whether SAF is associated with presence of AAA after correction for both cardiovascular risk factors (such as smoking) and cardiovascular comorbidity (expressed by a history of cerebrovascular disease (CVD) or coronary artery disease (CAD)).

8 Study population Boersema J, de Vos LC, Links TP, Mulder DJ, Smit AJ, Zeebregts CJ, Lefrandt JD. Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm. J Vasc Surg 2017 Dec; 66(6):

9 Patient characteristics Boersema J, de Vos LC, Links TP, Mulder DJ, Smit AJ, Zeebregts CJ, Lefrandt JD. Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm. J Vasc Surg 2017 Dec; 66(6):

10 Skin autofluorescence: AAA vs controls Boersema J, de Vos LC, Links TP, Mulder DJ, Smit AJ, Zeebregts CJ, Lefrandt JD. Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm. J Vasc Surg 2017 Dec; 66(6):

11 Influence of peripheral artery disease Boersema J, de Vos LC, Links TP, Mulder DJ, Smit AJ, Zeebregts CJ, Lefrandt JD. Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm. J Vasc Surg 2017 Dec; 66(6):

12 Multivariate analysis Boersema J, de Vos LC, Links TP, Mulder DJ, Smit AJ, Zeebregts CJ, Lefrandt JD. Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm. J Vasc Surg 2017 Dec; 66(6):

13 Influence of treatment Boersema J, de Vos LC, Links TP, Mulder DJ, Smit AJ, Zeebregts CJ, Lefrandt JD. Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm. J Vasc Surg 2017 Dec; 66(6):

14 Association between SAF and AAA Boersema J, de Vos LC, Links TP, Mulder DJ, Smit AJ, Zeebregts CJ, Lefrandt JD. Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm. J Vasc Surg 2017 Dec; 66(6):

15 Discussion (1) In several cardiovascular risk groups and disease, such as renal insufficiency, DM, CAD and PAD, AGE levels are increased compared to controls. The present study adds AAA patients as a high cardiovascular risk group with increased accumulation of AGEs. de Vos LC, Noordzij MJ, Mulder DJ, Smit AJ, Lutgers HL, Dullaart RPF, Kamphuisen PW, Zeebregts CJ, Lefrandt JD. Skin autofluorescence as a measure of advanced glycation endproducts deposition is elevated in peripheral artery disease. Arterioscler Thromb Vasc Biol 2013; 33: de Vos LC, Mulder DJ, Smit AJ, Dullaart RPF, Kleefstra N, Lijfering WM, Kamphuisen PW, Zeebregts CJ, Lefrandt JD. Skin autofluorescence is associated with 5 year mortality and cardiovascular events in peripheral artery disease. Arterioscler Thromb Vasc Biol 2014; 34: Schutte E, de Vos LC, Lutgers HL, Lambers Heerspink HJ, Wolffenbuttel BHR, Vart P, Zeebregts CJ, Gansevoort RT, Lefrandt JD. The association of skin autofluorescence levels with kidney function decline in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol 2016; 36:

16 Discussion (2) In a study of 8 AAA patients, AGEs and receptor for AGE in the aortic wall were increased as compared to 5 control samples from a tissue bank of autopsy materials. The same paper describes a reduction of incidence of AAA of 50% in AGE receptor knockout mice compared to control mice. Zhang F, Kent KC, Yamanouchi D, Zhang Y, Kato K, Tsai S, et al. Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm. Ann Surg 2009; 250:

17 Conclusions SAF, as a noninvasive assessment of skin accumulation of AGEs, is increased in patients with AAA compared with controls, independent of cardiovascular comorbidity. Still, within the AAA patients, SAF is closely associated with the presence of PAD and cardiovascular risk factors. These findings suggest that accumulation of AGEs is increased in AAA patients, partly explained by presence of widespread atherosclerosis.

18 Future studies ARTERY (advanced glycation endproducts in patients with peripheral artery disease and abdominal aneurysm) study

19 Acknowledgements Ellen Boersema Lisanne de Vos Joop Lefrandt Udo Mulder Andries Smit Maarten van der Laan Ben Saleem Paul van Schaik Ignace Tielliu Bas Wallis de Vries Thank you for your attention!

Perioperative mortality, paraplegia, stroke and long-term stent related complications after TEVAR for traumatic thoracic aortic lesions

Perioperative mortality, paraplegia, stroke and long-term stent related complications after TEVAR for traumatic thoracic aortic lesions Perioperative mortality, paraplegia, stroke and long-term stent related complications after TEVAR for traumatic thoracic aortic lesions Clark Zeebregts Professor of Vascular Surgery University Medical

More information

Quantification of abdominal aortic calcification: inherent measurement errors in current computed tomography imaging

Quantification of abdominal aortic calcification: inherent measurement errors in current computed tomography imaging Quantification of abdominal aortic calcification: inherent measurement errors in current computed tomography imaging Clark Zeebregts Professor of Vascular Surgery University Medical Center Groningen Department

More information

Clinical and Population Studies

Clinical and Population Studies Clinical and Population Studies Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Is Elevated in Peripheral Artery Disease Lisanne C. de Vos, Marjon J. Noordzij, Douwe J.

More information

Publication List Version: November 2012

Publication List Version: November 2012 Publication List Version: November 2012 AGE Reader Key Publications Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of

More information

Update on the fenestrated Anaconda endograft for F/EVAR: worldwide experience from the global FACT registry

Update on the fenestrated Anaconda endograft for F/EVAR: worldwide experience from the global FACT registry Update on the fenestrated Anaconda endograft for F/EVAR: worldwide experience from the global FACT registry Clark Zeebregts Professor of Vascular Surgery University Medical Center Groningen Department

More information

Advanced glycation end products as a biomarker for incisional hernia

Advanced glycation end products as a biomarker for incisional hernia Hernia (2017) 21:537 541 DOI 10.1007/s10029-017-1610-2 ORIGINAL ARTICLE Advanced glycation end products as a biomarker for incisional hernia J. J. Harlaar 1 H. H. Eker 2 K. A. Vakalopoulos 1 M. C. Cabezas

More information

Original Policy Date 12:2013

Original Policy Date 12:2013 MP 2.04.73 Non-Invasive Measurement of Advanced Glycation Endproducts (AGEs) in the Skin Medical Policy Section Medicine Issue 12:2013 Subsection Original Policy Date 12:2013 Last Review Status/Date Created

More information

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD Current Cholesterol Guidelines and Treatment of Residual Risk J. Peter Oettgen, MD Associate Professor of Medicine Harvard Medical School Director, Preventive Cardiology Beth Israel Deaconess Medical Center

More information

Joshua A. Beckman, MD. Brigham and Women s Hospital

Joshua A. Beckman, MD. Brigham and Women s Hospital Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham

More information

ARTICLE. H. L. Lutgers & E. G. Gerrits & R. Graaff & T. P. Links & W. J. Sluiter & R. O. Gans & H. J. Bilo & A. J. Smit

ARTICLE. H. L. Lutgers & E. G. Gerrits & R. Graaff & T. P. Links & W. J. Sluiter & R. O. Gans & H. J. Bilo & A. J. Smit DOI 10.1007/s00125-009-1308-9 ARTICLE Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type

More information

University of Groningen. Prediction and monitoring of chronic kidney disease Schutte, Elise

University of Groningen. Prediction and monitoring of chronic kidney disease Schutte, Elise University of Groningen Prediction and monitoring of chronic kidney disease Schutte, Elise IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

More information

Considerations for a Durable Repair

Considerations for a Durable Repair Considerations for a Durable Repair Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University, Nuremberg, Germany Disclosures William Cook

More information

Minimally Invasive Treatment Options for Renal Artery FMD

Minimally Invasive Treatment Options for Renal Artery FMD Minimally Invasive Treatment Options for Renal Artery FMD FMDSA Meeting 2016 Alan H. Matsumoto, M.D., FSIR, FACR, FAHA Professor and Chair Department of Radiology & Medical Imaging University of Virginia

More information

Experience of endovascular procedures on abdominal and thoracic aorta in CA region

Experience of endovascular procedures on abdominal and thoracic aorta in CA region Experience of endovascular procedures on abdominal and thoracic aorta in CA region May 14-15, 2015, Dubai Dr. Viktor Zemlyanskiy National Research Center of Emergency Care Astana, Kazakhstan Region Characteristics

More information

Endovascular Treatment of the Aorta with Fenestrated and Branched Grafts

Endovascular Treatment of the Aorta with Fenestrated and Branched Grafts Endovascular Treatment of the Aorta with Fenestrated and Branched Grafts Eric LG Verhoeven,MD, PhD, A. Katsargyris, MD Vascular and Endovascular Surgery, Paracelsus Medical University, Nuremberg, Germany

More information

Infections, inflammation and venous thrombosis; an epidemiological perspective Tichelaar, Ynse

Infections, inflammation and venous thrombosis; an epidemiological perspective Tichelaar, Ynse University of Groningen Infections, inflammation and venous thrombosis; an epidemiological perspective Tichelaar, Ynse IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF)

More information

Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice

Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University,

More information

EVAR follow up: answers to uncertainties Moderators F. Moll, Y. Alimi, M. Bjorck. Inflammatory response after EVAR: causes and clinical implication

EVAR follow up: answers to uncertainties Moderators F. Moll, Y. Alimi, M. Bjorck. Inflammatory response after EVAR: causes and clinical implication 39 th Annual Meeting, Boston, Sept. 2012 EVAR follow up: answers to uncertainties Moderators F. Moll, Y. Alimi, M. Bjorck Inflammatory response after EVAR: causes and clinical implication Christos D. Liapis,

More information

When to use standard EVAR with EndoAnchors or CHEVAR in short-neck AAAs LINC ASIA 18

When to use standard EVAR with EndoAnchors or CHEVAR in short-neck AAAs LINC ASIA 18 When to use standard EVAR with EndoAnchors or CHEVAR in short-neck AAAs JEAN-PAUL P.M. DE VRIES, DIRECTOR OF VASCULAR SURGERY ST.ANTONIUS HOSPITAL NIEUWEGEIN, THE NETHERLANDS. LINC ASIA-PACIFIC HongKong,

More information

Title: Elective Endovascular Abdominal Aortic Aneurism Repair versus Open Surgery: A Clinical and Cost Effectiveness Review

Title: Elective Endovascular Abdominal Aortic Aneurism Repair versus Open Surgery: A Clinical and Cost Effectiveness Review Title: Elective Endovascular Abdominal Aortic Aneurism Repair versus Open Surgery: A Clinical and Cost Effectiveness Review Date: 07 April 2008 Context and policy issues: Abdominal aortic aneurism (AAA)

More information

Advanced glycation end products in patients with peripheral artery disease de Vos, Lisanne Carlijn

Advanced glycation end products in patients with peripheral artery disease de Vos, Lisanne Carlijn University of Groningen Advanced glycation end products in patients with peripheral artery disease de Vos, Lisanne Carlijn IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's

More information

Supplement materials:

Supplement materials: Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction

More information

Exceptions to the Rules: Abdominal and Thoracic Aneurysms

Exceptions to the Rules: Abdominal and Thoracic Aneurysms Exceptions to the Rules: Abdominal and Thoracic Aneurysms Jason Bayne MD, FRCSC Vascular Surgery Jewish General Hospital Assistant Professor, Program Director McGill University Objectives Risk factors

More information

Medical management of abdominal aortic aneurysms

Medical management of abdominal aortic aneurysms Medical management of abdominal aortic aneurysms Definition of AAA - Generally a 50% increase in native vessel diameter - Diameter 3 cm - Relative measures compared with nondiseased aortic segments less

More information

Three year experience with multilayer stent in the treatment of thoracoabdominal aneurysms no evidence for aneurysm stabilization

Three year experience with multilayer stent in the treatment of thoracoabdominal aneurysms no evidence for aneurysm stabilization Three year experience with multilayer stent in the treatment of thoracoabdominal aneurysms no evidence for aneurysm stabilization Thomas Larzon, MD, PhD Head of Vascular Surgery Dept of Cardiothoracic

More information

Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE)

Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE) Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE) Jan MM Heyligers, PhD, FEBVS Consultant Vascular Surgeon The Netherlands

More information

Endovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad).

Endovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad). Endovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad). AS. Eleshra, MD 1, T. Kölbel, MD, PhD 1, F. Rohlffs, MD 1, N. Tsilimparis, MD, PhD 1,2 Ahmed Eleshra

More information

General introduction. Chapter 1

General introduction. Chapter 1 Chapter 1 Despite a better understanding of the aetiology and pathophysiology of atherothrombotic vascular disease, and the availability of effective treatment modalities, the burden of vascular disease

More information

Metabolism and Atherogenic Properties of LDL

Metabolism and Atherogenic Properties of LDL Metabolism and Atherogenic Properties of LDL Manfredi Rizzo, MD, PhD Associate Professor of Internal Medicine Faculty of Medicine, University of Palermo, Italy & Affiliate Associate Professor of Internal

More information

CONTRIBUTING FACTORS FOR STROKE:

CONTRIBUTING FACTORS FOR STROKE: CONTRIBUTING FACTORS FOR STROKE: HYPERTENSION AND HYPERCHOLESTEROLEMIA Melissa R. Stephens, MD, FAAFP Associate Professor of Clinical Sciences William Carey University College of Osteopathic Medicine LEARNING

More information

10/17/16. Assessing cardiovascular risk through use of inflammation testing

10/17/16. Assessing cardiovascular risk through use of inflammation testing Assessing cardiovascular risk through use of inflammation testing Anthony L. Lyssy, DO Medical Director and Managing Partner Diamond Physicians Dallas, TX Response to Injury Hypothesis Injury Response

More information

A FAMILY HISTORY OF ABDOMINAL AORTIC ANEURYSM (AAA) DISEASE

A FAMILY HISTORY OF ABDOMINAL AORTIC ANEURYSM (AAA) DISEASE Important Information for You and Your Family A FAMILY HISTORY OF ABDOMINAL AORTIC ANEURYSM (AAA) DISEASE Have you been diagnosed with AAA disease? There is a 15% chance that one of your family members

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany

Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany Disclosures Speaker name: Dittmar Böckler I have the following potential conflicts

More information

DECLARATION OF CONFLICT OF. No conflict INTEREST

DECLARATION OF CONFLICT OF. No conflict INTEREST DECLARATION OF CONFLICT OF No conflict INTEREST Mangement of Polyvascular Disease Diagnostic work-up Augusto Gallino, Bellinzona Switzerland ESC, Paris, august 29 th 2011 Polyvascular Disease In the last

More information

University of Groningen. Diabetes mellitus and rhegmatogenous retinal detachment Fokkens, Bernardina Teunisje

University of Groningen. Diabetes mellitus and rhegmatogenous retinal detachment Fokkens, Bernardina Teunisje University of Groningen Diabetes mellitus and rhegmatogenous retinal detachment Fokkens, Bernardina Teunisje IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you

More information

Volume 3 (2017) Issue 1 ISSN Abstract. Keywords fenestrated after open repair; Pararenal abdominal aortic aneurysm.

Volume 3 (2017) Issue 1 ISSN Abstract. Keywords fenestrated after open repair; Pararenal abdominal aortic aneurysm. Open Journal of Clinical & Medical Case Reports Volume 3 (2017) Issue 1 ISSN 2379-1039 Fenestrated stent-graft after previous open surgical repair of abdominal aortic aneurysm: case report and review of

More information

Registry of Endovascular Aneurysm Registry data report

Registry of Endovascular Aneurysm Registry data report SPECIAL REPORT Lifeline Repair: Registry of Endovascular Aneurysm Registry data report Lifeline Registry of Endovascular Aneurysm Repair Steering Committee Purpose: The goal of the Lifeline Endovascular

More information

Clinical Outcomes Among Vascular Procedure Patients Receiving Suture-mediated vs Surgical Cutdown for Closure of Large-bore Arterial Access

Clinical Outcomes Among Vascular Procedure Patients Receiving Suture-mediated vs Surgical Cutdown for Closure of Large-bore Arterial Access Clinical Outcomes Among Vascular Procedure Patients Receiving Suture-mediated vs Surgical for Closure of Large-bore Arterial Access Ramon L. Varcoe, MBBS, MS, FRACS, PhD Associate Professor of Vascular

More information

Mimecan and cardiac extracellular matrix integrity Lucas Van Aelst, MD Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium

Mimecan and cardiac extracellular matrix integrity Lucas Van Aelst, MD Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium Mimecan and cardiac extracellular matrix integrity Lucas Van Aelst, MD Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium VIB-Vesalius Research Center, KULeuven, Leuven, Belgium

More information

Patient selection in Hostile Necks and how. to prevent endoleaks a word of caution

Patient selection in Hostile Necks and how. to prevent endoleaks a word of caution Patient selection in Hostile Necks and how to prevent endoleaks a word of caution P M Kasprzak, K. Pfister Department of Vascular Surgery Endovascular Surgery University Hospital Regensburg, Germany Conflict

More information

University of Groningen. Covered stents in aortoiliac occlusive disease Grimme, Frederike. DOI: /j.ejvs /j.jvir

University of Groningen. Covered stents in aortoiliac occlusive disease Grimme, Frederike. DOI: /j.ejvs /j.jvir University of Groningen Covered stents in aortoiliac occlusive disease Grimme, Frederike DOI: 10.1016/j.ejvs.2014.08.009 10.1016/j.jvir.2015.04.007 IMPORTANT NOTE: You are advised to consult the publisher's

More information

INCRAFT system: Update from the Pivotal INSPIRATION Study

INCRAFT system: Update from the Pivotal INSPIRATION Study INCRAFT system: Update from the Pivotal INSPIRATION Study Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh

More information

Clinical Investigation and Reports. Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction

Clinical Investigation and Reports. Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction Clinical Investigation and Reports Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction The Rotterdam Study Irene M. van der Meer, MD, PhD; Michiel L. Bots, MD,

More information

Research Article Abdominal Aortic Aneurysms and Coronary Artery Disease in a Small Country with High Cardiovascular Burden

Research Article Abdominal Aortic Aneurysms and Coronary Artery Disease in a Small Country with High Cardiovascular Burden ISRN Cardiology, Article ID 825461, 4 pages http://dx.doi.org/10.1155/2014/825461 Research Article Abdominal Aortic Aneurysms and Coronary Artery Disease in a Small Country with High Cardiovascular Burden

More information

OHTAC Recommendation

OHTAC Recommendation OHTAC Recommendation of Abdominal Aortic Aneurysms for Low Surgical Risk Patients Presented to the Ontario Health Technology Advisory Committee in October, 2009 January 2010 Background In 2005, the Ontario

More information

Reduction in cardiovascular related adverse events following active sac management with Nellix vs. EVAR: Are there biological advantages?

Reduction in cardiovascular related adverse events following active sac management with Nellix vs. EVAR: Are there biological advantages? February 1, 2018 Reduction in cardiovascular related adverse events following active sac management with Nellix vs. EVAR: Are there biological advantages? Patrick Berg M.D. Marienhospital Kevelaer Germany

More information

Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD

Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD Sao Paulo Medical School Hospital Sao Paulo, Brazil Disclosure Honoraria received for consult and/or speaker : Astra Zeneca, Amgen,

More information

I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical Department National Taiwan University Hospital

I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical Department National Taiwan University Hospital Comparisons of Aortic Remodeling and Outcomes after Endovascular Repair of Acute and Chronic Complicated Type B Aortic Dissections I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical

More information

Aortic Aneurysms: What s s New?

Aortic Aneurysms: What s s New? 25th Annual Advances in Heart Disease 12 December 2008 Aortic Aneurysms: What s s New? Melvin D. Cheitlin, M.D., MACC Emeritus Professor of Medicine UCSF 1 AAA in the U.S. 13th cause of death -16,000 deaths/yr

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Peripheral arterial disease Potential output:

More information

Abdominal Aortic Aneurysm

Abdominal Aortic Aneurysm Abdominal Aortic Aneurysm David N. Duddleston, MD VP and Medical Director Southern Farm Bureau Life Jackson, Mississippi A Case Ms. Ima Bolgin,, age 54, $1.2 million, sent to you for review. Smoker, ½

More information

Declaration of conflict of interest. Dominique de Kleijn is founder of a UMC Utrecht spin-off biomarker company Cavadis BV

Declaration of conflict of interest. Dominique de Kleijn is founder of a UMC Utrecht spin-off biomarker company Cavadis BV Declaration of conflict of interest Dominique de Kleijn is founder of a UMC Utrecht spin-off biomarker company Cavadis BV BIOMARKERS OF DISEASE Microvesicle proteins as diagnostic and predictive biomarkers

More information

No Disclosure. Aortic Dissection in Japan. This. The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair

No Disclosure. Aortic Dissection in Japan. This. The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair No Disclosure The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair Toru Kuratani Department of Cardiovascular Surgery Osaka University Graduate School of Medicine,

More information

Abdominal Aortic Aneurysms (AAA): Management in 2012

Abdominal Aortic Aneurysms (AAA): Management in 2012 Abdominal Aortic Aneurysms (AAA): Management in 2012 Matthew S. Edwards, MD, MS, FACS Associate Professor of Surgery and Public Health Sciences Department of Vascular and Endovascular Surgery General Considerations

More information

University of Groningen

University of Groningen University of Groningen Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study van Waateringe, Robert; Slagter, Sandra; van der Klauw, Melanie; Ostaptchouk, Jana;

More information

Side effects of TEVAR and EVAR on the heart: Myth or reality?

Side effects of TEVAR and EVAR on the heart: Myth or reality? Side effects of TEVAR and EVAR on the heart: Myth or reality? Christos D. Liapis, MD, FACS, FRCS, FEBVS Professor (Em) of Vascular Surgery National & Kapodistrian University of Athens Director Vascular

More information

Calcium scoring Clinical and prognostic value

Calcium scoring Clinical and prognostic value Calcium scoring Clinical and prognostic value Matthijs Oudkerk Professor and Chair of Radiology University Medical Center Groningen, University of Groningen Groningen, The Netherlands Sofia 2011 13 May

More information

Targeting nanoparticles to degenerated elastin: A new pathway to deliver drugs for pulmonary and cardiovascular diseases

Targeting nanoparticles to degenerated elastin: A new pathway to deliver drugs for pulmonary and cardiovascular diseases Targeting nanoparticles to degenerated elastin: A new pathway to deliver drugs for pulmonary and cardiovascular diseases Naren Vyavahare, Saketh Karamched, Aniqa Chowdhury, Vaideesh Parasaram. Nasim Nosoudi,

More information

Surgery for patients with diffuse atherosclerotic disease

Surgery for patients with diffuse atherosclerotic disease Surgery for patients with diffuse atherosclerotic disease Special hospital for surgery Skopje Macedonia September, 2012 Mitrev Z, Anguseva T, E.Stoicovski, Hristov N, E.Idoski Oktomvri, 2008 Atherosclerosis

More information

Preliminary data from the Liège Screening Programme Suggests the Reported Decline in AAA Prevalence is not Global

Preliminary data from the Liège Screening Programme Suggests the Reported Decline in AAA Prevalence is not Global Preliminary data from the Liège Screening Programme Suggests the Reported Decline in AAA Prevalence is not Global Georgios Makrygiannis, MD Department of Cardiovascular Surgery, and Surgical Research Center,

More information

Aneurysms & a Brief Discussion on Embolism

Aneurysms & a Brief Discussion on Embolism Aneurysms & a Brief Discussion on Embolism Aneurysms, overview = congenital or acquired dilations of blood vessels or the heart True aneurysms -involve all three layers of the artery (intima, media, and

More information

SUPPLEMENTARY DATA. Table of Contents

SUPPLEMENTARY DATA. Table of Contents Table of Contents Supplemental Figure S1. Kaiser Permanente Diabetes Registry Patient Flow Diagram Supplemental Table S1. Diagnostic and procedure codes and frequency of events during follow-up for outcomes

More information

Goals of Screening Programs. What is Vascular Screening? Assumptions Regarding the Potential Benefits of Screening Programs PAD

Goals of Screening Programs. What is Vascular Screening? Assumptions Regarding the Potential Benefits of Screening Programs PAD Conflict of Interest Disclosure (Relationships with Industry) An Epidemic of : The Debate Over Population Screening Membership on an advisory board, consultant, or recipient of a research grant from the

More information

Pulse wave velocity, augmentation index and arterial age in students

Pulse wave velocity, augmentation index and arterial age in students Pulse wave velocity, augmentation index and arterial age in students IOANA MOZOS 1, SERBAN GLIGOR 2 1 Department of Functional Sciences Victor Babes University of Medicine and Pharmacy Timisoara ROMANIA

More information

Complex Thoracic and Abdominal Aortic Repair Using Hybrid Techniques

Complex Thoracic and Abdominal Aortic Repair Using Hybrid Techniques Complex Thoracic and Abdominal Aortic Repair Using Hybrid Techniques Tariq Almerey MD, January Moore BA, Houssam Farres MD, Richard Agnew MD, W. Andrew Oldenburg MD, Albert Hakaim MD Department of Vascular

More information

About OMICS Group Conferences

About OMICS Group Conferences About OMICS Group OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of

More information

The presenter does not have any potential conflicts of interest to disclose

The presenter does not have any potential conflicts of interest to disclose Carotid intima-media thickness as a predictor of multi territory atherosclerotic occlusive disease in patients with symptomatic subclavian artery obstruction Leszek Wrotniak 1, Anna Kabłak Ziembicka 1,

More information

Nellix Endovascular System: Clinical Outcomes and Device Overview

Nellix Endovascular System: Clinical Outcomes and Device Overview Nellix Endovascular System: Clinical Outcomes and Device Overview Jeffrey P. Carpenter, MD Professor and Chief, Department of Surgery CAUTION: Investigational device. This product is under clinical investigation

More information

What is the benefit. of MEP s in BEVAR for TAAA. in preventing paraplegia?

What is the benefit. of MEP s in BEVAR for TAAA. in preventing paraplegia? What is the benefit of MEP s in BEVAR for TAAA in preventing paraplegia? P M Kasprzak Department of Vascular Surgery, Endovascular Surgery University Hospital Regensburg, Germany Disclosures Dr. Kasprzak

More information

Disclosure. I do not have any potential conflict of interest

Disclosure. I do not have any potential conflict of interest Endovascular repair of ruptured abdominal aortic aneurysms is superior to open repair in risk stratified patients: a look at the United States experience through the SVS Vascular Quality Initiative 2003

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Quality ID #259: Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post Operative

More information

Aortoiliac stenting: is CERAB replacing kissing stents from a flow dynamic perspective? Michel MPJ Reijnen Rijnstate Hospital Arnhem, The Netherlands

Aortoiliac stenting: is CERAB replacing kissing stents from a flow dynamic perspective? Michel MPJ Reijnen Rijnstate Hospital Arnhem, The Netherlands Aortoiliac stenting: is CERAB replacing kissing stents from a flow dynamic perspective? Michel MPJ Reijnen Rijnstate Hospital Arnhem, The Netherlands Disclosure Speaker name: MMPJ Reijnen I have the following

More information

The Many Faces of T2DM in Long-term Care Facilities

The Many Faces of T2DM in Long-term Care Facilities The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment

More information

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for + Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics

More information

ACC NY Cardiovascular Symposium

ACC NY Cardiovascular Symposium ACC NY Cardiovascular Symposium Peripheral Vascular Disease: Watch the Heart and the Brain Evolving Role of Exercise, ACE-Inhibitors, Interventional and Surgical Options Mark A. Creager, M.D President,

More information

Problem patients in primary care Patient 4: Peripheral artery disease

Problem patients in primary care Patient 4: Peripheral artery disease Problem patients in primary care Patient 4: Peripheral artery disease Dr Terry McCormack Hambleton Richmond Whitby Clinical Commissioning Group Research Lead 01/05/2014 Delivering clinical research to

More information

Importance of changes in thoracic and abdominal aortic stiffness following stent graft implantation

Importance of changes in thoracic and abdominal aortic stiffness following stent graft implantation 14/9/2018 Importance of changes in thoracic and abdominal aortic stiffness following stent graft implantation Christos D. Liapis, MD, FACS, FRCS, FEBVS Professor (Em) of Vascular Surgery National & Kapodistrian

More information

Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery

Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2008 Update Plus Overview of the Guidelines Concept John Coyle, M.D. October 16, 2008 The History of Medicine As Mountaineering Feat

More information

Paraplegia in endovascular repair of TAA and in TEVAR: Incidence, prevention and therapy. Johannes Lammer Medical University Vienna, Austria

Paraplegia in endovascular repair of TAA and in TEVAR: Incidence, prevention and therapy. Johannes Lammer Medical University Vienna, Austria Paraplegia in endovascular repair of TAA and in TEVAR: Incidence, prevention and therapy Johannes Lammer Medical University Vienna, Austria Conflict of interests: none 68y, male, PAU in coral reef aorta,

More information

The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease

The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease Interventional Cardiology and Cath Labs The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease Manesh R. Patel MD Chief,

More information

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events. ACETYL SALICYLIC ACID TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

More information

An Overview of Post-EVAR Endoleaks: Imaging Findings and Management. Ravi Shergill BSc Sean A. Kennedy MD Mark O. Baerlocher MD FRCPC

An Overview of Post-EVAR Endoleaks: Imaging Findings and Management. Ravi Shergill BSc Sean A. Kennedy MD Mark O. Baerlocher MD FRCPC An Overview of Post-EVAR Endoleaks: Imaging Findings and Management Ravi Shergill BSc Sean A. Kennedy MD Mark O. Baerlocher MD FRCPC Disclosure Slide Mark O. Baerlocher: Current: Consultant for Boston

More information

The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema

The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,

More information

Cardiovascular manifestations of HIV

Cardiovascular manifestations of HIV Cardiovascular manifestations of HIV Prabhakar Rajiah, MBBS, MD, FRCR Associate Professor of Radiology Associate Director, Cardiac CT and MRI University of Texas Southwestern Medical Center, Dallas, USA

More information

Case Presentation Conference Ravi Dhanisetty, M.D. Kings County Hospital Center

Case Presentation Conference Ravi Dhanisetty, M.D. Kings County Hospital Center Case Presentation Morbidity and Mortality Conference Ravi Dhanisetty, M.D. Kings County Hospital Center 1 May 2009 Case Presentation 53 year old male bus driver had a syncopal episode and found down unresponsive.

More information

Jes S. Lindholt. The role of fish oil in the natural history of abdominal aortic aneurysms. J Am Heart Assoc Jan 26;7(3).

Jes S. Lindholt. The role of fish oil in the natural history of abdominal aortic aneurysms. J Am Heart Assoc Jan 26;7(3). The role of fish oil in the natural history of abdominal aortic aneurysms J Am Heart Assoc. 2018 Jan 26;7(3). Jes S. Lindholt Professor in Vascular Surgery, DMSci, Ph.D. Odense University Hospital, Denmark.

More information

Keeping the Small Aortic Aneurysm Small

Keeping the Small Aortic Aneurysm Small Keeping the Small Aortic Aneurysm Small John A. Curci, MD, FACS Associate Professor of Vascular and Endovascular Surgery Director, Aortic Aneurysm Research Laboratories, Washington University Principal

More information

VDF and The Burden of Vascular Disease

VDF and The Burden of Vascular Disease VESSEL: The Annual Meeting of the VDF September 23,2012 VDF and The Burden of Vascular Disease David P. Faxon MD President Elect VDF Vice Chair of Medicine Brigham and Women s Hospital Disclosures: Boston

More information

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients Cardiovascular Mortality: General Population vs ESRD Dialysis Patients Annual CVD Mortality (%) 100 10 1 0.1 0.01 0.001 25-34 35-44 45-54 55-64 66-74 75-84 >85 Age (years) GP Male GP Female GP Black GP

More information

DONOR CORONARY ANGIOGRAPHY PROTOCOL

DONOR CORONARY ANGIOGRAPHY PROTOCOL Guidance Document DONOR CORONARY ANGIOGRAPHY PROTOCOL ATCA-TSANZ Guidelines 002/2015 Version 1.0, 27 March 2015 1 Table of Contents 1 Purpose 2 Preamble Introduction 4 Donor Heart Allocation protocol 4

More information

PERIPHERAL ARTERIAL DISEASE (PAD); Frequency in diabetics.

PERIPHERAL ARTERIAL DISEASE (PAD); Frequency in diabetics. PERIPHERAL ARTERIAL DISEASE (PAD); Frequency in diabetics. ORIGINAL PROF-2084 Dr. Qaiser Mahmood, Dr. Nasreen Siddique, Dr. Affan Qaiser ABSTRACT Objectives: (1) To determine the frequency of PAD in diabetic

More information

A tool to identify type 2 diabetic patients at risk for developing microvascular complications

A tool to identify type 2 diabetic patients at risk for developing microvascular complications Emerging Treatments and Technologies O R I G I N A L A R T I C L E Skin Autofluorescence A tool to identify type 2 diabetic patients at risk for developing microvascular complications ESTHER G. GERRITS,

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary 2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth

More information

The Struggle to Manage Stroke, Aneurysm and PAD

The Struggle to Manage Stroke, Aneurysm and PAD The Struggle to Manage Stroke, Aneurysm and PAD In this article, Dr. Salvian examines the management of peripheral arterial disease, aortic aneurysmal disease and cerebrovascular disease from symptomatology

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease

More information

Improving Endograft Durability with EndoAnchors

Improving Endograft Durability with EndoAnchors Improving Endograft Durability with EndoAnchors William D. Jordan, Jr., M.D. John E. Skandalakis Chair in Surgery Professor and Chief Division of Vascular Surgery and Endovascular Therapy Emory University

More information

Psoriasi e rischio CV

Psoriasi e rischio CV Psoriasi e rischio CV Claudio Borghi Dipartimento di Scienze Mediche e Chirurgiche Università di Bologna David Plunkert 5 Biggest Heart Risks for Men Plos Med, 2006 Sequenza di eventi che causano malattie

More information